Thomas Cole
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 26
- Surgery top 0.2%
- Lipoproteins and Cardiovascular Health 27
- Cholesterol and Lipid Metabolism 4
-
- Lipid metabolism and disorders 8
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 15
- Economics and Econometrics top 0.5%
-
- Diet and metabolism studies 8
-
- Atherosclerosis and Cardiovascular Diseases 5
-
- Peroxisome Proliferator-Activated Receptors 4
- Co-authors
- Frank M. SacksMarc A. PfefferLemuel A. MoyéBarry R. DavisEugene BraunwaldJean L. RouleauLisa BrownJ. Wayne Warnica
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Thomas Cole
64 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Endocrinology, Diabetes and Metabolism 3.6k
- Surgery 6.3k
- Cardiology and Cardiovascular Medicine 2.7k
- Cancer Research 1.4k
- Economics and Econometrics 1.7k
Countries citing papers authored by Thomas Cole
This map shows the geographic impact of Thomas Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cole more than expected).
Fields of papers citing papers by Thomas Cole
This network shows the impact of papers produced by Thomas Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cole. The network helps show where Thomas Cole may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 7 | |
| 3 | 2004 | 9 | |
| 4 | 2004 | 42 | |
| 5 | 2000 | 110 | |
| 6 | 1999 | 6 | |
| 7 | 1999 | 12 | |
| 8 | 1998 | 10 | |
| 9 | 1998 | 274 | |
| 10 | 1996 | 8 | |
| 11 | 1996 | 12 | |
| 12 | The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levelsbreakdown → | 1996 | 5701 |
| 13 | 1996 | 14 | |
| 14 | 1995 | 18 | |
| 15 | 1991 | 95 | |
| 16 | 1991 | 92 | |
| 17 | 1990 | 127 | |
| 18 | 1990 | 123 | |
| 19 | 1983 | 23 | |
| 20 | Modulation of hepatic tri glyceride and ketone body output by dexamethasone | 1979 | 1 |
About Thomas Cole
Thomas Cole is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Surgery, Biochemistry and Physiology, having authored 64 papers that have together received 9.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers), Cancer, Lipids, and Metabolism (15 papers), Diet and metabolism studies (8 papers), Lipid metabolism and disorders (8 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.6k citations), Surgery (6.3k citations), Cardiology and Cardiovascular Medicine (2.7k citations), Cancer Research (1.4k citations) and Economics and Econometrics (1.7k citations). Thomas Cole has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, Barry R. Davis, Eugene Braunwald, Jean L. Rouleau, Lisa Brown, J. Wayne Warnica, John D. Rutherford and Chuan‐Chuan Wun. Their work appears in journals such as Clinical Chemistry, Journal of Lipid Research, Circulation, Metabolism and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.